Health Equity in Patients Receiving Durvalumab for Unresectable Stage III Non-Small Cell Lung Cancer in the US Veterans Health Administration.

Amanda M Moore Zohra Nooruddin Kelly R Reveles Jim M KoellerJennifer M WhiteheadKathleen FranklinParomita Datta Munaf Alkadimi Lance Brannman Ion Cotarla Andrew J Frankart Tiernan J MulrooneyXavier JonesChristopher R Frei

Published in: The oncologist (2023)

Race was not found to be linked with TID, TI, or TD in this real-world study of patients with unresectable stage III NSCLC treated with durvalumab at the VHA.

Keyphrases

public health
healthcare
mental health
health information
locally advanced
small cell lung cancer
liver metastases
squamous cell carcinoma
health promotion
radiation therapy
risk assessment
rectal cancer
tyrosine kinase
social media